Skip to main content
Parnax Lab Limited logo

Parnax Lab Limited — Investor Relations & Filings

Ticker · 506128 ISIN · INE383L01019 BSE.NS Manufacturing
Filings indexed 286 across all filing types
Latest filing 2024-09-05 Annual Report
Country IN India
Listing BSE.NS 506128

About Parnax Lab Limited

https://naxparlab.com

Parnax Lab Limited specializes in the development and large-scale manufacturing of pharmaceutical formulations, with a primary focus on liquid orals, ointments, creams, and gels. The company operates advanced production facilities compliant with international quality benchmarks, including WHO-GMP standards. It functions as a contract development and manufacturing organization (CDMO), providing end-to-end solutions from formulation development to commercial production for global and domestic healthcare brands. The product range encompasses diverse therapeutic areas such as dermatology, gastrointestinal health, and pediatric care. By integrating modern technology with rigorous quality control processes, the company ensures the delivery of high-stability medicinal products. Its operations are supported by a dedicated research and development wing focused on optimizing delivery systems and enhancing product efficacy for various clinical applications.

Recent filings

Filing Released Lang Actions
Annual Report for the Financial Year 2023-24
Annual Report Classification · 100% confidence The document is titled '42nd Annual Report 2023-2024' for Parnax Lab Limited and contains detailed sections typical of an annual report, including statutory reports, directors report, management discussion and analysis, CEO/CFO certification, corporate governance report, secretarial audit report, and comprehensive standalone and consolidated financial statements with auditor's reports, balance sheets, profit and loss statements, and cash flow statements. The presence of detailed financial statements and audit reports confirms this is the full annual report document, not just an announcement or summary. The document length is substantial (15,000 characters), supporting that it is a full report rather than a brief notice or announcement. Therefore, the appropriate classification is Annual Report (10-K).
2024-09-05 English
Notice of 42nd Annual General Meeting schedule to be held on Friday, 27th September, 2024.
Regulatory Filings
2024-09-05 English
Book Closure Intimation for the upcoming Annual General Meeting (AGM) schedule to be held on Friday, 27th September, 2024.
Regulatory Filings
2024-09-05 English
Newspaper Advertisement w.r.t. publication of Notice to Shareholders for Registration/Updation of their Emails, etc.
Regulatory Filings Classification · 95% confidence The document text is a lengthy notice primarily related to a public works tender by the Thane Municipal Corporation and a miscellaneous application in a debt recovery tribunal involving Dewan Housing Finance Corporation Limited. It includes legal notices, auction announcements, and procedural details related to a tribunal case. There is no indication of financial statements, earnings data, management discussion, or investor presentations. The content is legal and regulatory in nature, focusing on court proceedings and public tender announcements rather than corporate financial reporting or governance disclosures. The document does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified under Regulatory Filings (RNS) as it contains miscellaneous regulatory and legal notices that do not fit other specific categories.
2024-09-02 English
Please find enclosed herewith the Standalone and Consolidated Financial Results for the Quarter and Three Months Ended June 30, 2024
Regulatory Filings
2024-08-14 English
Board Meeting Outcome for Approval of Unaudited Financial Standalone and Consolidated Results for the Quarter Ended June, 2024.
Regulatory Filings
2024-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.